Sunday, March 8, 2026 3/8/2026

Stimulus-evoked directional field potentials to guide subthalamic and pallidal DBS for PD

Award Number: UH3NS130202
ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
OPDIV: NIH
AWARD CLASS: COOPERATIVE AGREEMENT
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 12/18/2023
PERIOD OF PERFORMANCE END DATE: 11/30/2028

Group Awards By:

View Award Description

Stimulus-evoked directional field potentials to guide subthalamic and pallidal DBS for PD - Parkinson’s disease and other movement disorders are by far the most common indications for deep brain stimulation (DBS) worldwide. Despite intense and ongoing investigation, there are no established biomarkers to identify optimal stimulation locations and parameters with increasingly complex directional and adaptive DBS devices. Here we will collaborate with our industry partner Boston Scientific to pioneer use of their novel 16- contact directional Argyle lead, informed by their emerging stimulation and recording architecture, NEXT (Neuromodulation Experimental Testbed). We will use advanced experimental and analytic methods to generate detailed spatiotemporal maps of stimulus-evoked electrophysiology in the subthalamic nucleus versus globus pallidus interna in patients with Parkinson’s disease, both awake and under general anesthesia. We will then create predictive models from these spatial maps to guide directional DBS activation and clinical programming. Our overall goal is to pair our novel analytic methods with emerging device technologies to develop predictive biomarkers to guide directional DBS therapy for Parkinson’s disease and other complex neurocognitive disorders. Our vision, and that of our industry collaborator, is for next-generation DBS devices to integrate these technologies into fully implanted devices that can reveal crucial interactions between DBS and human brain circuits to guide clinical decision-making at the point of care during both surgical targeting and clinical programming.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2026 ( Subtotal = $1,531,491 )
2026	2026	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	001	3	3/5/2026	NON-COMPETING CONTINUATION	$153,148
2026	2026	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	3	12/5/2025	NON-COMPETING CONTINUATION	$1,378,343
														Subtotal = $1,531,491

Issue Date FY: 2025 ( Subtotal = $1,382,351 )
2025	2025	UNIVERSITY OF ALABAMA AT BIRMINGHAM	701 S 20TH STREET	BIRMINGHAM	AL	35294	JEFFERSON	USA	Extramural Research Programs in the Neurosciences and Neurological Disorders	000	2	1/24/2025	EXTENSION WITH OR WITHOUT FUNDS	$1,382,351
														Subtotal = $1,382,351

Grand Total All Awards = $2,913,842

Top

All Categories

About

Search

Reports

Data Submission

Award Information

Stimulus-evoked directional field potentials to guide subthalamic and pallidal DBS for PD

Award Number: UH3NS130202

ORGANIZATION: NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE

OPDIV: NIH

AWARD CLASS: COOPERATIVE AGREEMENT

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 12/18/2023

PERIOD OF PERFORMANCE END DATE: 11/30/2028

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer